Leading the Fight Against Cancer
We equip students with the interdisciplinary education, laboratory experience and career skills they’ll need to excel in cancer research.
M.S. Info Sessions
The past two decades have seen a revolution in the study of cancer biology. Advances in molecular biology, biochemistry and cell biology have contributed to our understanding of malignant transformation, cancer prevention and cancer therapy. The Georgetown University Interdisciplinary Program in Tumor Biology provides doctoral and master’s students with an excellent academic environment and interdisciplinary training for a career in cancer biology research. Our students develop their potential to produce highest-quality research and academic scholarship.
Join Us in 2027!
Ph.D. Summer Admission Deadline: December 1
M.S. Fall Admission Early Application: January 15 – apply early to waive the application fee!
M.S. Fall Admission Priority Application: May 15
M.S. Fall Admission Final Deadline: July 1
Attend an online information session to learn about our programs:
The Georgetown Difference
Our program brings together about 60 faculty members from basic science and clinical departments, as well as the expertise and resources of Georgetown’s Lombardi Comprehensive Cancer Center, a National Cancer Institute-designated Comprehensive Cancer Center that combines excellence in basic and clinical cancer research, as well as research on cancer control and prevention.
A combination of formal courses, seminars, and ongoing collaborative research projects bring together faculty and trainees in a unified doctoral program committed to providing quality education in cancer biology, prevention, and therapy.
Alumni Success
Coursework, lab experience, mentorship and career development resources all empower our students to pursue impactful careers.
M.S. Alumni Outcomes M.S. and Ph.D. Career ServicesNews
The Association of American Cancer Institutes’ 2026 Cancer Health Equity Award recognizes individuals or groups who demonstrate exceptional leadership in promoting health equity at their cancer cent…
July 12th, 2026
Groundbreaking Cancer Researcher Richard Schlegel Moves to Emeritus Role
Work from Schlegel’s lab was foundational to the development of the first HPV vaccine – heralded as the first “cancer vaccine” in the world. Schlegel’s team developed a technique known as conditio…
June 26th, 2026
BGE’s Evergreen Gap Fund Awardees Advance Cutting-Edge Research
BGE faculty and a student are among the latest recipients of the university’s Evergreen Gap Fund awards for innovative research projects – including in a new category of Catalyst Awards for very early…
June 23rd, 2026